What BRAVE Analytics does

BRAVE Analytics GmbH is an Austrian instrumentation company headquartered in Graz that develops and sells real-time nanoparticle and particle characterization systems based on its proprietary OF2i® (OptoFluidic Force Induction) method. The technology delivers number-based particle sizing and concentration data with single-particle accuracy across a range from 5 nm to 80 µm, including dedicated detection of large particles and PFAT5 contamination relevant to injectable pharmaceuticals and semiconductor wet processes. The product portfolio spans laboratory instruments (standalone OF2i® particle sizing and concentration, OF2i® + Raman for combined sizing and chemical identification, large-particle/PFAT5 detection, and a triple-coupling OF2i® + Raman + ICP-MS module co-developed with three Graz universities) and Process Analytical Technology (PAT) sensors for continuous in-line production monitoring, complemented by fee-for-service contract measurements.

The company sells primarily to enterprise customers in pharmaceuticals, biotechnology, cosmetics, environmental analysis, and semiconductor manufacturing, with additional reference activity in academic and applied research. Go-to-market is a hybrid model: direct enterprise sales with technical consultation and live demonstrations, supported by a network of nine specialized regional distributors covering Austria, UK/Ireland, Greece, the Benelux, South Korea, Japan, Vietnam, and Taiwan. Pricing is quote-based with no publicly disclosed list prices, and revenue is generated through instrument sales, PAT sensor sales, and contract measurement services. The firm has participated in EU HORIZON 2020 consortia (NanoPAT and MOZART) and receives Austrian funding via FFG and AWS, indicating active R&D investment and government backing. BRAVE Analytics remains a privately held GmbH with 11–50 employees, co-led by CEO/CTO Christian Hill and COO/CFO Gerhard Prossliner.

Name

BRAVE Analytics

Legal name

BRAVE Analytics GmbH

Website

https://braveanalytics.eu

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

BRAVE Analytics GmbH is a Graz-based instrumentation company that provides real-time nanoparticle and particle characterization using its proprietary OF2i® technology, serving pharmaceutical, biotech, cosmetics, environmental, and semiconductor customers through laboratory devices, PAT sensors, and contract measurement services.

Ownership category

akta.pro rank

Product category

Particle Characterization Instrumentation

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Other Measuring and Controlling Device Manufacturing (334519), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Laboratory Analytical Instruments (3826), Industrial Instruments For Measurement, Display, And Control (3823), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Process Analytical Instrumentation (Gas analyzers, spectroscopy, pH/ORP, conductivity) (IMAGAFAE)

akta.pro secondary industries

Mass Spectrometry & Spectroscopy Instruments (HLAGAIAB), Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES) (HLAAAJAE), Process Industries IIoT (Oil & Gas/Chemicals/Pharma/Food) (IMAIAMAM)

Keywords

• Nanoparticle characterization instruments
• Process analytical technology sensors
• Single-particle size measurement
• Raman spectroscopy instrumentation
• Particle contamination detection

Headquarters

HQ city

Graz

HQ country

Austria

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Laboratory Equipment Sales: Sale of laboratory particle analysis instruments including OF2i® systems, Raman analyzers, and large particle detection systems (PFAT5/LPC). Instruments are sold directly to laboratories and through distribution partners.
2. PAT Sensor Sales: Sale of Process Analytical Technology sensors for continuous production monitoring in manufacturing environments, particularly for pharmaceuticals and semiconductor industries.
3. Contract Measurements: Fee-for-service particle analysis measurements for customers who need specialized analysis without purchasing equipment.

Go-to-market motion2 records

Distribution channels9 records

Marketing channels6 records

Core offering

BRAVE Analytics develops and sells laboratory instruments and Process Analytical Technology (PAT) sensors based on its proprietary OF2i® (OptoFluidic Force Induction) method for real-time, single-particle characterization of nanoparticles and microparticles. Offerings are configured as standalone OF2i® systems, OF2i® combined with Raman spectroscopy, and OF2i® combined with Raman and ICP-MS, and are sold to pharmaceutical, biotech, cosmetics, semiconductor, and environmental analysis laboratories through direct enterprise sales and a network of regional scientific-instrument distributors.

Product overview

BRAVE Analytics offers a portfolio of laboratory and PAT (Process Analytical Technology) devices for particle analysis based on their proprietary OF2i® (OptoFluidic Force Induction) technology. The core OF2i® platform delivers number-based particle characterization with single-particle accuracy and is available in three configurations: standalone OF2i®, OF2i® + Raman spectroscopy for combined sizing and chemical identification, and OF2i® + Raman + ICP-MS for comprehensive single particle characterization. The product line also includes dedicated lab devices for particle sizing/concentration (5 nm to 3 µm), Raman analysis, and large particle/PFAT5 detection (2 µm to 80 µm), as well as PAT sensors for continuous production monitoring. Contract measurement services complement the hardware offerings.

Differentiator

Problem solved

Functional benefit

Products and services

• OF2i® (OptoFluidic Force Induction) particle analyzer Standalone proprietary OF2i®-based system that delivers number-based nanoparticle and particle characterization with single-particle accuracy, supporting detection of impurities, large particles, continuous monitoring of particle size distribution, and real-time observation of time-critical processes. Intended for laboratory and PAT users in pharmaceutical, biotech, cosmetics, environmental, and semiconductor settings.
• OF2i® + Raman analyzer Combined OF2i® and Raman spectroscopy platform providing number-based particle sizing together with chemical identification of particles, particularly suited to continuous in-flow particle analysis.
• OF2i® + Raman + ICP-MS single-particle platform Triple-coupling platform integrating OF2i®, Raman spectroscopy, and Inductively Coupled Plasma Mass Spectrometry for combined size, chemical, and elemental characterization of individual particles.
• Particle sizing, counts and concentration lab device Laboratory instrument for measuring particle size, particle concentration, and size distribution, covering 5 nm to 3 µm, with minimal sample preparation required.
• Raman analysis lab device Laboratory device for Raman spectroscopic analysis enabling chemical identification of particles in flow, including microplastics in water without sample preparation.
• Large particle and PFAT5 lab device Laboratory instrument for detecting and sizing large particles from 2 µm to 80 µm, including PFAT5 (Particulate Contamination) detection for quality control in pharmaceutical and semiconductor applications.
• PAT sensors for continuous production monitoring Process Analytical Technology sensors for continuous monitoring of particle processes in production environments, enabling real-time quality control during manufacturing, particularly for pharmaceutical and semiconductor operations.
• Contract measurement services Fee-for-service particle analysis measurements performed by BRAVE Analytics for customers across pharmaceuticals, biotech, cosmetics, environmental analysis, and semiconductors who need specialized data without purchasing an instrument.

Quantifiable outcome

• Sample volume of only 20µL required for representative measurements
• +1 more outcomes

Named customers10 records

Segments6 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

20 partnerships are on record, tiered core and minor.

• NanoPAT ConsortiumcoreStrategic or Co-development PartnerEU HORIZON 2020 research project (Grant Agreement No. 862583) focused on Process Analytical Technology for nanoparticle characterization. BRAVE Analytics received EU funding as a partner in this collaborative research initiative involving multiple European institutions.
• MOZART ProjectcoreStrategic or Co-development PartnerEU HORIZON 2020 project (MOZART for safe & sustainable by-design metallic coatings & engineered surfaces). BRAVE Analytics received funding as a partner focusing on innovative analytical approaches.
• FluidnovaminorStrategic or Co-development PartnerListed as a BRAVE partner organization, though specific partnership details are limited on the website.
• Medical University of GrazcoreStrategic or Co-development PartnerKey academic research partner with multiple collaborative projects. Professor Tobias Madl, Prof. Sebastian Schwamminger, and Dr. Karin Kornmüller from this institution have provided testimonials and engaged in research collaborations.
• Technische Universität Graz (TU Graz)coreStrategic or Co-development PartnerKey academic partner including Harald Fitzek from the Institute of Electron Microscopy and Nanoanalysis (FELMI-ZFE) and multiple collaborative research engagements.
• Universität GrazcoreStrategic or Co-development PartnerAcademic research partner including Ass. Prof. David Clases engaged in biophysical research using BRAVE technologies.
• BioNanoNet Forschungsgesellschaft (BNN)minorStrategic or Co-development PartnerResearch association partner including Beatriz Alfaro Serrano who has provided testimonial for OF2i technology applications.
• Creative NanominorStrategic or Co-development PartnerPartner including Dr. Alexandros Zoikis Karathanasis, CEO, who has provided testimonial and conducted test installations of OF2i technology.
• Fresenius KabicoreStrategic or Co-development PartnerMajor pharmaceutical company partner with Christoph Koeth (Senior Director Innovation) involved in testing BRAVE Online device for pharmaceutical production monitoring.
• FLUIDINOVAminorStrategic or Co-development PartnerManufacturing partner including Dr. Catarina Coelho from R&D working on particle size measurement systems for production environments.
• LignovationsminorStrategic or Co-development PartnerCosmetics company partner with Martin Miltner (CEO) exploring OF2i applications for cosmetic formulation development.
• Human Technology StyriaminorStrategic or Co-development PartnerRegional technology network in Styria, Austria.
• MOULAS ScientificcoreChannel Partner/ Reseller/ DistributorOfficial distribution partner for Greece since 2007. Specializes in laboratory equipment, consumables, and components distribution and installation.
• SciSPX (Beun-De Ronde)coreChannel Partner/ Reseller/ DistributorDistribution partner for Belgium, Netherlands, and Luxembourg. Specializes in sample preparation and analytics solutions for analytical, QC, and process laboratories.
• Bob Korea Ltd.coreChannel Partner/ Reseller/ DistributorDistribution partner for South Korea. Specializes in physicochemical equipment for nanomaterial R&D through manufacturing and production.
• Dyna Research Lab Co., Ltd.coreChannel Partner/ Reseller/ DistributorDistribution partner for Japan. Specializes in modern spectroscopic technologies and innovative analysis solutions for R&D.
• BETA TECHNOLOGY Co., Ltd.coreChannel Partner/ Reseller/ DistributorDistribution partner for Vietnam. Offers modern, precise, and reliable analytical solutions, combining experience in laboratory equipment with technical expertise.
• Jige Scientific Instruments Co., Ltd.coreChannel Partner/ Reseller/ DistributorDistribution partner for Taiwan (semiconductor applications). Specializes in analytical instrumentation and technical support for semiconductor industry applications.
• Prager ElektronikcoreChannel Partner/ Reseller/ DistributorDistribution partner for Austria since 1993. Specializes in particle/polymer characterization, rheology, and flow measurement equipment. Since 2024 provides service and support for BRAVE Analytics devices in Austria.
• Analytik LtdcoreChannel Partner/ Reseller/ DistributorDistribution partner for UK and Ireland. Supplies state-of-the-art scientific instruments to leading organizations. Founded March 2003, based in Swavesey near Cambridge.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Postnova Analytics: Niche particle and nanoparticle characterization specialist using field-flow fractionation; serves similar pharma, polymer, and nanoparticle research customers as BRAVE.

Direct peers

• Wyatt Technology: Specializes in light-scattering and separation-based tools for macromolecule and nanoparticle characterization (SEC-MALS, DLS, FFF), addressing the same biologics and nanoparticle customers as BRAVE.
• Malvern Panalytical: Global leader in particle characterization (laser diffraction, DLS, NTA, imaging). Direct competitor across pharma, biotech, and materials with deep installed base and broad application libraries.
• Horiba Scientific: Provides particle characterization (laser diffraction, DLS, Raman, spectroscopy) instruments across pharma, semiconductor, and academic markets; overlaps with BRAVE's Raman and particle analysis offerings.
• Particle Measuring Systems: Specializes in cleanroom particle counters and contamination monitoring for pharmaceutical and semiconductor manufacturing, directly competing with BRAVE's large-particle / PFAT5 product line.
• Beckman Coulter / Microtrac: Particle sizing and characterization portfolio (laser diffraction, DLS, image analysis) sold to similar pharma, materials, and academic customers; competes head-to-head with OF2i in lab and PAT settings.
• TSI Incorporated: Manufactures particle counters and sizers for cleanroom, pharmaceutical, and environmental monitoring; competes in the large-particle / PFAT5 / contamination detection segment of BRAVE's portfolio.

Broad incumbents

• Agilent Technologies: Major analytical instrument and ICP-MS vendor; competes with BRAVE's ICP-MS-coupled configurations and provides adjacent chromatography/spectroscopy solutions used by the same pharma customers.
• Thermo Fisher Scientific: Diversified analytical instruments leader offering spectroscopy, mass spectrometry, and particle characterization under multiple brands; can bundle competing solutions across pharma and biotech.
• Shimadzu Scientific Instruments: Broad analytical instrument portfolio (spectroscopy, chromatography, mass spec) serving pharma, environmental, and semiconductor customers that overlap with BRAVE's target verticals.

Market position

Strengths5 records

Weaknesses1 record

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@braveanalytics
• LinkedInlinkedin.com/company/brave-analytics-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BRAVE Analytics